Skip to main content Back to Top
Advertisement

1/31/2023

Ibuprofen Oral Suspension (Prescription Products Only)

Products Affected - Description

    • Ibuprofen oral suspension, Taro, 100 mg/5 mL, 118 mL bottle, NDC 51672-1385-08
    • Ibuprofen oral suspension, Taro, 100 mg/5 mL, 473 mL bottle, NDC 51672-1385-09
    • Ibuprofen oral suspension, Teva, 100 mg/5 mL, 120 mL bottle, NDC 00472-2002-94
    • Ibuprofen oral suspension, Teva, 100 mg/5 mL, 473 mL bottle, NDC 00472-2002-16

Reason for the Shortage

    • Teva did not provide a reason for the shortage.
    • Taro was not available to provide information.

Available Products

    • There are no presentations available

Estimated Resupply Dates

    • Teva discontinued ibuprofen 100 mg/5 mL oral suspension 120 mL and 473 mL bottles.
    • Taro has ibuprofen 100 mg/5 mL oral suspension 120 mL and 473 mL bottles on backorder and the company estimates a resupply date of March 2023.

Alternative Agents & Management

    • Multiple over-the-counter products may be available.

Updated

Updated January 31, 2023 by Rachael Freeman, PharmD, BCPS. Created November 29, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.